Add to favorites

Revolutionizing Cancer Treatment: MR-Linac VMAT Breakthrough

Researchers at the University of Iowa and University Medical Center Utrecht have made a significant breakthrough in cancer treatment by incorporating volumetric-modulated arc therapy (VMAT) delivery capabilities into the MR-linac. This innovation could improve plan quality and efficiency, reduce patient discomfort, and make MRI-guided treatments more accessible to patients. The team demonstrated that VMAT deliveries are possible on the Elekta Unity, a 1.5 T MR-linac, without requiring changes to clinical hardware.
  • Forecast for 6 months: Within the next 6 months, we expect to see the first clinical trials of VMAT on MR-linacs, paving the way for wider adoption of this technology in cancer treatment.
  • Forecast for 1 year: By the end of the year, we anticipate that several major cancer treatment centers will have implemented VMAT on their MR-linacs, leading to improved treatment outcomes and patient satisfaction.
  • Forecast for 5 years: In the next 5 years, VMAT on MR-linacs is expected to become the standard of care for cancer treatment, with widespread adoption and integration into clinical workflows.
  • Forecast for 10 years: By the end of the decade, we predict that VMAT on MR-linacs will have revolutionized cancer treatment, leading to significant reductions in treatment times, improved patient outcomes, and enhanced quality of life for millions of patients worldwide.

Tags: , ,

Related

Leave a Reply

Your email address will not be published. By submitting this form, you agree to our Privacy Policy. Required fields are marked *

Wordpress Social Share Plugin powered by Ultimatelysocial
RSS
Follow by Email
X (Twitter)
WhatsApp
Mastodon
RateItAll
IncreasingHappiness
URL has been copied successfully!